Ocular Therapeutix Inc (OCUL)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$1.50B
EV to revenue ratio (TTM)
17.83
EV to ebitda
-6.06
Financial Performance
Revenue (TTM)
$0.05B
Gross profit (TTM)
-$0.20B
EBITDA
-$0.34B
Profitability
Operating margin (TTM)
-760.00%
Profit margin
<0.01%
Return on assets (TTM)
-42.20%
Return on equity (TTM)
-93.50%
Per Share Metrics
Revenue per share (TTM)
$0.23
EPS
-$1.44
Diluted EPS (TTM)
-$1.44
Book value
$2.01
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
n/a
PEG ratio
0
Price to sales ratio (TTM)
29.86
Price to book ratio (TTM)
2.78
Growth
Quarterly earnings growth (YoY)
-11.50%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
4
Buy
8
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.22